Search Results - "Bodenmueller, Wolfram"

Additional Data in Expanded Patient Populations and New Indications Support the Practice of Biosimilar-to-Biosimilar Switching by Cohen, Hillel P., Bodenmueller, Wolfram

“…As of 31 December, 2023, 31 observational studies have been published, including a total of 6081 patients who underwent a switch from one biosimilar to another…”
Get full text

Switching from One Biosimilar to Another Biosimilar of the Same Reference Biologic: A Systematic Review of Studies by Cohen, Hillel P., Hachaichi, Sohaib, Bodenmueller, Wolfram, Kvien, Tore K., Danese, Silvio, Blauvelt, Andrew

“…Background Multiple switches (transitions) between biosimilars of the same reference biologic are now a reality, and they are expected to become more common in…”
Get full text

Clinical and mechanistic aspects of glucocorticoid-induced chemotherapy resistance in the majority of solid tumors by Zhang, Chengwen, Wenger, Till, Mattern, Jürgen, Ilea, Septimia, Frey, Christian, Gutwein, Paul, Altevogt, Peter, Bodenmüller, Wolfram, Gassler, Nikolaus, Schnabel, Philipp A., Dienemann, Hendrik, Marmé, Alexander, Hohenfellner, Markus, Haferkamp, Axel, Pfitzenmaier, Jesco, Gröne, Hermann-Josef, Kolb, Armin, Büchler, Peter, Büchler, Markus, Friess, Helmut, Rittgen, Werner, Edler, Lutz, Debatin, Klaus-Michael, Krammer, Peter H., Rutz, Hans P., Herr, Ingrid

“…Background: Glucocorticoids have been used widely in conjunction with cancer therapy due to their ability to induce apoptosis in hematological cells and to…”
Get full text